open access

Vol 88, No 1 (2017)
Research paper
Published online: 2017-01-31
Get Citation

Using our own developed stent in the palliative treatment of obstruction in the left half of the colon due to ovarian cancer

Tomasz Miłek, Konrad Pasek, Piotr Ciostek, Habib Alkalaya, Agnieszka Timorek, Włodzimierz Sawicki, Krzysztof Cendrowski
·
Pubmed: 28157254
·
Ginekol Pol 2017;88(1):1-4.

open access

Vol 88, No 1 (2017)
ORIGINAL PAPERS Gynecology
Published online: 2017-01-31

Abstract

Objectives: An assessment of implantation efficacy and safety of self-developed self-expanding stent in patients with an ovarian cancer induced by intestinal obstruction.

Material and methods: The study of the stenting efficacy and safety was realized prospectively. The group consisted of 13 patients with left half colon obstruction due to an inoperable metastatic ovarian carcinoma. All the patients had a histopathologically diagnosed ovarian carcinoma and were treated in the past both surgically and systemically. Stenting was preceded by a Computed Tomography (CT) scan confirming and locating the obstruction. Patients with a multilevel intestinal obstruction were disqualified.

Results: Nine stents were implanted in the rectosigmoid; 4 stents were implanted in an externally compressed rectum. One migration of implanted stent was observed. In one case 2 stents were implanted due to an insufficient coverage of the stricture. The decompression of the obstruction of the gastrointestinal tract was achieved in 11 patients (85%).

Conclusions: 1) The implantation of our own developed, self-expanding stent is effective and safe. 2) The implantation of the stent in patients with an inoperable ovarian cancer causing an obstruction of the gastrointestinal tract is an effective procedure limiting postoperative complications and improving life comfort by avoiding stoma.

Abstract

Objectives: An assessment of implantation efficacy and safety of self-developed self-expanding stent in patients with an ovarian cancer induced by intestinal obstruction.

Material and methods: The study of the stenting efficacy and safety was realized prospectively. The group consisted of 13 patients with left half colon obstruction due to an inoperable metastatic ovarian carcinoma. All the patients had a histopathologically diagnosed ovarian carcinoma and were treated in the past both surgically and systemically. Stenting was preceded by a Computed Tomography (CT) scan confirming and locating the obstruction. Patients with a multilevel intestinal obstruction were disqualified.

Results: Nine stents were implanted in the rectosigmoid; 4 stents were implanted in an externally compressed rectum. One migration of implanted stent was observed. In one case 2 stents were implanted due to an insufficient coverage of the stricture. The decompression of the obstruction of the gastrointestinal tract was achieved in 11 patients (85%).

Conclusions: 1) The implantation of our own developed, self-expanding stent is effective and safe. 2) The implantation of the stent in patients with an inoperable ovarian cancer causing an obstruction of the gastrointestinal tract is an effective procedure limiting postoperative complications and improving life comfort by avoiding stoma.

Get Citation

Keywords

cancer-induced intestinal obstruction, ovarian carcinoma, stent

About this article
Title

Using our own developed stent in the palliative treatment of obstruction in the left half of the colon due to ovarian cancer

Journal

Ginekologia Polska

Issue

Vol 88, No 1 (2017)

Article type

Research paper

Pages

1-4

Published online

2017-01-31

Page views

1436

Article views/downloads

1828

DOI

10.5603/GP.2016.0098

Pubmed

28157254

Bibliographic record

Ginekol Pol 2017;88(1):1-4.

Keywords

cancer-induced intestinal obstruction
ovarian carcinoma
stent

Authors

Tomasz Miłek
Konrad Pasek
Piotr Ciostek
Habib Alkalaya
Agnieszka Timorek
Włodzimierz Sawicki
Krzysztof Cendrowski

References (13)
  1. Baron TH. Colonic stenting: a palliative measure only or a bridge to surgery? Endoscopy. 2010; 42(2): 163–168.
  2. Dohmoto M, Hünerbein M, Schlag PM. Application of rectal stents for palliation of obstructing rectosigmoid cancer. Surg Endosc. 1997; 11(7): 758–761.
  3. Tejero E, Mainar A, Fernández L, et al. New procedure for the treatment of colorectal neoplastic obstructions. Dis. Colon Rectum. 1994; 37(11): 1158–1159.
  4. Keswani RN, Azar RR, Edmundowicz SA, et al. Stenting for malignant colonic obstruction: a comparison of efficacy and complications in colonic versus extracolonic malignancy. Gastrointest. Endosc. 2009; 69(3 Pt 2): 675–680.
  5. Shrivastava V, Tariq O, Tiam R, et al. Palliation of obstructing malignant colonic lesions using self-expanding metal stents: a single-center experience. Cardiovasc Intervent Radiol. 2008; 31(5): 931–936.
  6. Jost RS, Jost R, Schoch E, et al. Colorectal stenting: an effective therapy for preoperative and palliative treatment. Cardiovasc Intervent Radiol. 2007; 30(3): 433–440.
  7. Watt AM, Faragher IG, Griffin TT, et al. Self-expanding metallic stents for relieving malignant colorectal obstruction: a systematic review. Ann. Surg. 2007; 246(1): 24–30.
  8. Small AJ, Coelho-Prabhu N, Baron TH. Endoscopic placement of self-expandable metal stents for malignant colonic obstruction: long-term outcomes and complication factors. Gastrointest. Endosc. 2010; 71(3): 560–572.
  9. Köhler G, Antoniou SA, Lechner M, et al. Stenting for Emergency Colorectal Obstruction: An Analysis of 204 Patients in Relation to Predictors of Failure and Complications. Scand J Surg. 2015; 104(3): 146–153.
  10. Caceres A, Zhou Q, Iasonos A, et al. Colorectal stents for palliation of large-bowel obstructions in recurrent gynecologic cancer: an updated series. Gynecol. Oncol. 2008; 108(3): 482–485.
  11. Rubin SC, Hoskins WJ, Benjamin I, et al. Palliative surgery for intestinal obstruction in advanced ovarian cancer. Gynecol. Oncol. 1989; 34(1): 16–19.
  12. Kim JiW, Jeong JiB, Lee KL, et al. Comparison of clinical outcomes between endoscopic and radiologic placement of self-expandable metal stent in patients with malignant colorectal obstruction. Korean J Gastroenterol. 2013; 61(1): 22–29.
  13. Aadam AA, Martin JA. Enteral stents in malignant bowel obstruction. Gastrointest. Endosc. Clin. N. Am. 2013; 23(1): 153–164.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl